SCHEDULE: M28 Capital Discloses 5.9% Stake in Curis Inc.
Beneficial Ownership Report
M28 Capital Management LP and Marc Elia have disclosed a 5.9% beneficial ownership stake in Curis Inc., including shares issuable from warrants.
Summary
- M28 Capital Management LP and Marc Elia, collectively referred to as the 'Reporting Persons', have reported beneficial ownership of 620,167 shares of Curis Inc. Common Stock.
- This ownership represents 5.9% of Curis Inc.'s outstanding Common Stock.
- The reported amount includes 99,108 shares of Common Stock issuable upon the exercise of warrants.
- The percentage of class is calculated based on 10,561,358 shares of Common Stock outstanding as of May 2, 2025, as reported in Curis Inc.'s Quarterly Report on Form 10-Q for the period ended March 31, 2025.
- The shares are held with shared voting power and shared dispositive power by the Reporting Persons.
- The M28 Fund, managed by M28 Capital, has the right to receive dividends or proceeds from the sale of these securities.
- The securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing the control of Curis Inc.
Sentiment
Score: 5
Explanation: The filing is a factual disclosure of beneficial ownership, which is neutral in sentiment. It indicates a significant investment but provides no performance or operational updates.
Future Outlook
This Schedule 13G filing is a disclosure of beneficial ownership and does not contain forward-looking statements or guidance regarding the issuer's future performance or outlook.
Industry Context
This filing is a standard disclosure of a significant passive investment in a publicly traded company within the biotechnology sector. It reflects an investment firm's position rather than a strategic industry move by the issuer.
Stakeholder Impact
- Shareholders: The disclosure of a significant passive stake by an investment firm can be viewed positively as a vote of confidence or as a potential precursor to future engagement, though the filing explicitly states the investment is not for control purposes.
Key Dates
| Date | Description |
|---|---|
| 2025-05-02 | Date of outstanding shares calculation (10,561,358 shares) as reported in Curis Inc.'s 10-Q. |
| 2025-06-30 | Date of event which required the filing of this statement (beneficial ownership threshold crossed). |
| 2025-08-13 | Date of filing of this Schedule 13G Amendment No. 1. |
Keywords
Curis Inc., M28 Capital Management, Marc Elia, Beneficial Ownership, Common Stock, SEC Filing, Schedule 13G, Investment Management, Biotechnology Investment
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.